Author:
Chen Hong,Zhang Jingxiao,Hu Peixin,Qian Yuna,Li Jing,Shen Jianliang
Funder
National Natural Science Foundation of China
Zhejiang Provincial Natural Science of Foundation of China
Wenzhou Medical University and Wenzhou Institute of Biomaterials & Engineering
Henan Province Science and Technology Attack Plan Foundation
Applied Science and Technology Research Foundation of Luoyang Normal University
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference52 articles.
1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018
2. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018;Ferlay;Eur J Cancer,2018
3. Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate cancer;Dorff;Curr Opin Urol,2013
4. Loblaw DA, Walker-Dilks C, Winquist E, Hotte SJ, G.C.D.S.G. of C.C.O.P., in: E.-B. Care (Ed.). Systemic therapy in men with metastatic castration-resistant prostate cancer: a systematic review. Clin Oncol (R Coll Riodiol). 2013;25:406–430.
5. Tetramethylpyrazine hydrochloride inhibits proliferation and apoptosis in human prostate cancer PC3 cells through Akt signaling pathway;Han;J Third Mil Med Univ,2013
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献